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11.1 months in INI1 + tumours as compared to 6.5 months in
INI1 – tumours. No patients were alive in the un-methylated and
INI1 – tumour subgroup.
Conclusions: In our series, at the level of protein expression by
immunohistochemistry, loss of INI1 in GBM may be indicating an
underlying molecular aberration accounting for the more aggressive
clinical behaviour.
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Human astrocytomas are well known for their histological diversity.
In connection with a retrospective clinico-pathological study on low-
grade astrocytomas during the time period 1987–2007, all patients
found in the hospital electronic patient data base, were investigated.
Paraffin-sections re-examined, and tumours were classified according
to the WHO 2007 criteria. All grade II astrocytomas were included
(n = 96). The aim of the present study was to unveil the multitude of
histological features in this type of astrocytoma.
Of special variants we defined approximately 92% as fibrillary, 5%
as gemistocytic, and 3% as protoplasmic astrocytomas. In some
tumours smaller areas with protoplasmic and gemistocytic appear-
ance were seen. Cell density and cellular/nuclear atypia were pre-
dominantly judged to be low to moderate. Occasional mitoses were
identified in about 25% of the tumours, and apoptotic figures
occurred in about 40%. Microcystic changes, microcalcification, and
Rosenthal fibres were seen in 37%, 5%, and 10%, respectively. In
about 60% of the cases secondary changes were found, distributed
as perineuronal (56%), angiocentric (22%), and subpial growth
(16%).
Our findings verify the heterogeneous histology of grade II astrocyto-
mas making this diagnosis often challenging, emphasizing the need
to a continuous evaluation of classification systems in conjunction
with correlations between histology and survival.
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Introduction: Spatial distribution of hypoxia inducible factor 1-alpha
(HIF-1a), vascular endothelial growth factor (VEGF), phosphatase of
regenerating liver-3 (PRL3) and matrix metalloproteinase-9 (MMP9)
was compared in progressive grades of glioma and metastatic lesions.
MRI parameters relating to hypoxia, invasiveness and angiogenesis
were compared with marker expression.
Materials and Methods: 65 cases of Glioma including 5 grade-I, 15
grade-II, 4 grade III, 41 grade IV and 5 metastatic tumors. Biopsies
were graded and classified by WHO classification (2007), immuno-
stained & percentage tumor cells quantified. Conventional and DCE-
MRI with implementation of pharmacokinetic model was for perme-
ability (Ktrans and Kep) calculation and analysis of concentration
time curve for hemodynamic indices (CBV and CBF). Institutional
ethical approvals were obtained. One way ANOVA was performed
for marker expression across groups & Pearson’s correlation among
perfusion indices and markers
Results: Invading tumor cells expressed PRL3, MMP9 and VEGF.
HIF-1a was focal. Endothelial cells expressed VEGF and PRL3 in
high grade lesions. In all groups, kep and ktrans showed a posi-
tive correlation with MMP-9 expression, while VEGF correlated
with CBV.
Table 1. IHC parameters in tumors.
Tumor PRL3 VEGF
HIF
(in hot spots) MMP9
Glioma Grade 1 52.6 + 32.7 17.2 + 16.8 9.0 + 7.24 30.0 + 21.2
Glioma Grade 2 54.6 + 26.7 16.5 + 10.2 17.7 + 11.3 37.4 + 22.4
Glioma Grade 3 62.5 + 17.0 28.7 + 11.5 28.0 + 8.52 35.0 + 5.47
Glioma Grade 4 61.6 + 28.6 47.2 + 11.3 34.7 + 18.8 48.5 + 19.2
Metastases 88.5 + 9.8 86.5 + 4.6 27.5 + 12.3 72.0 + 6.7
(figures denote mean + SD)
Conclusion: MR perfusion parameters correlated with VEGF expres-
sion while permeability indices correlated with MMP9.
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It is claimed that human glioblastomas (GBM) have a highly variable
histologic appearance. In a retrospective clinico-pathological study
on primary glioblastomas during the time period 1997–2006, a total
number of 193 tumours were included. Available paraffin-sections
were re-examined, and multiple histopathological features were
recorded.
Most cases were classified as ‘classical’ GBM (92%), but subtypes
like giant cell- and small cell glioblastoma were diagnosed as well
(1% and 7%, respectively) Further, a mixture of different types of
tumour cells were common including gemistocytes, epiteloid, granu-
lar, spindle, small cells, and giant cells. Oligodendroglial components
were observed in 5%. Cellularity varied from low to high and atypia
from mild to severe. Necroses were observed in almost all cases
(99%) and occurred as focal, large, and bland necrosis in 16%,
29%, and 54%, respectively. Mitotic activity varied considerably
with a median of 8 (range 0–64) per 10 HPF. Among other findings
were: pseudopallisading 83%, microvascular proliferation 83%, ap-
toptotic figures 100%, desmoplasia 42%, nucleoli 49%, and micro-
calcification 12%. Secondary phenomena observed were subpial-
(10%), perineural- (24%), and angiocentric growth (19%).
Our findings confirm the histological heterogeneity of this tumour,
which is appropriate with its previous name glioblastoma multi-
forme. For this reason, the diagnosis of this tumour is challenging in
such a way that immunohistochemistry and molecular genetic analy-
ses may be required. Nevertheless, the combination of pleomorphic
cells, necrosis, and microvascular proliferation strongly favours the
diagnosis of a GBM.
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Metastatic and secondary neoplasms affect the central nervous sys-
tem either by bloodborne dissemination from a distant site or by
direct local extension. Metastatic neoplasms are common intracra-
nial masses with expansive growth pattern encountered both at sur-
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gery and autopsy. Adults are primarily affected. Metastatic carci-
noma to the brain usually affects the cerebral hemispheres and/or the
cerebellum. To describe the immunohistochemical aspects of intra-
parenquimatous metastases to the central nervous system, the
authors describe 169 cases of metastases evaluated between 1995
and 2008. The brain and the cerebellum were the most common sites
of metastases (about 75%), being the lungs (22.36%), the kidneys
(16.21%), the breast (14.85%) and the colon (8.1%) the most fre-
quent primary sites. No association was found in relation with the
primary neoplasm and the site of metastases (P = 0.125). The immu-
noistochemical analysis was performed in 76 cases, and the expres-
sion of the antibodies, in special cytokeratins pattern, was able to
suggest the primary site in all cases, making this method a special
step to study theses lesions.
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A major focus of surgical neuropathology has been to associate
tumor classification based on histopathologic features to clinical data
and immunohistochemical features to determine clinicopathologic
entities. Advances in neuroimaging techniques now permit precise
tumor localization and accurate sampling of multiple areas within
heterogeneous tumors. To describe the histological types of primary
central nervous system tumors associated to localization, age, gender
and immunohistochemical features, the authors describe 821 cases of
primary tumors evaluated between 1995 and 2008. The most com-
mon histological types were glioblastoma, diffuse astrocytoma and
meningioma (WHO grade 1), with association between tumor locali-
zation and age. The immunoistochemical analysis was performed in
48 cases of malignant undifferentiated neoplasias, and the expression
of the antibodies was able to suggest the tumor differentiation, mak-
ing this method a special step to study theses lesions.
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The differential diagnosis of low grade astrocytoma and reactive gli-
osis can be a challenging problem in surgical neuropathology in the
era of stereotactic and navigation-guided biopsies, usually yielding
small tissue samples. Numerous criteria for differential diagnosis
have been proposed, including Ki67 labeling index, p53 staining, etc.
These are not very helpful and demonstrate significant overlap
between gliosis and astrocytoma. Peripheral benzodiazepine receptor
(PBR) is composed of a multiprotein complex located on the contact
site between inner and outer mitochondrial membranes. PBR is
found in various peripheral organs and glial cells of the central ner-
vous system. The function of PBR in the glia is not clear, but it has
been established that PBR expression is significantly increased in
‘activated’ reactive astrocytes in neurodegenerative, inflammatory
and demyelinative diseases. We proposed that immunohistochemical
staining for PBR could be useful in differentiating reactive gliosis
from low grade astrocytoma.
Paraffin sections from 35 cases of astrocytoma (WHO grades I and
II) and 25 cases of reactive gliosis (caused by brain metastases, cra-
niopharyngiomas, pineocytomas, demyelinative lesions and post-radi-
ation gliosis) were stained for Ki-67, p53 and PBR. Both Ki-67
labeling index and p53 expression demonstrated no significant differ-
ences in the cases of gliosis and astrocytomas. However, immunohis-
tochemical staining for PBR demonstrated striking differences in
astrocytomas and gliosis. Most astrocytomas showed negative results
on PBR staining, while weak focal staining was observed in three
cases only.
In all the cases of reactive gliosis, strong to moderate cytoplasmic
staining for PBR was seen. This difference was even more striking in
cases of gliosis with pilocytes and Rosenthal fibers vs. pilocytic astro-
cytoma and gliosis with gemistocytes vs. gemistocytic astrocytoma.
According to our results, immunohistochemical staining for PBR
may provide a useful tool for differentiating between low grade
astrocytomas and reactive astrogliosis, especially helpful in small
samples of tissue.
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Primary central nervous system lymphomas, (PCNSL) is now
thought to constitute about 0.8–6.6% of all intracranial neoplasms
and its occurence is still growing up. These tumours most commonly
arise in the deep cerebral structures including periventricular white
matter, corpus callosum, cerebellum, spinal cord. Modern standards
of PCNSL diagnosing comprise stereotactic biopsy of the tumour
with subsequent histopathological and immunohistochemical differ-
entiation. Diagnosing of malignant small-cell brain tumours may be
difficult, especially when only biopsy material is available, but open
resection of PCNSL may lead to worse therapeutic effect. The best
schema of the treatment is still discussed.
We analysed data of 232 patients subjected to stereotactic biopsy
(Brain-Lab system) of deep CNS tumors in last 9 years. Routinely
stained smears (Harris hematoxylin& eosin) were prepared for intraop-
erative cytologic diagnosing. Remaining material underwent histologi-
cal and immunohistochemical investigations (LCA, CD79alfa and
CD20, CD3, CD2, CD4, CD8, CD10, CD15, CD30, ALK1 Protein, Bcl
6, light chains lambda and kappa, pan CK, EMA, Ki67 labelling index).
Histological and immunohistochemical investigations enabled us to
diagnose 38 PCNSL: 32 B-cell, 3 T-cell, 1 B-cell-T-cell rich and two
anaplastic large-cell lymphoma according to WHO (2008) classifica-
tion. In 24 cases establishing diagnosis on the basis of cytologic smears
was difficult, sometimes impossible, because of significant cell necrosis.
Cytologic diagnostics of stereotactic bioptates of PCNSL is difficult,
because steroids recomended before surgery to prevent herniation,
cause necrosis of the tumour. Ultra-small tissue samples obtained by
stereotactic biopsy are sufficient to establish a correct diagnosis in
PCNSL cases and to implement correct patients treatment.
Po10-14
Development of myofibroblastic sarcoma in
meningioma: a new variant of ‘metaplastic’
meningioma
Lach B
Department of Pathology and Molecular Medicine, McMaster
University, Hamilton, Ontario, Canada
Myofibroblastic tumours of meninges are extremely uncommon; only
a few cases were previously described, including one with sarcoma-
tous change.
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